These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4807074)

  • 1. [Behavior of electrocardiographic and rheographic tracings in atherosclerotic subjects treated with clofibrate].
    Furitano G; Aguglia V
    Boll Soc Ital Cardiol; 1973; 18(4):357-60. PubMed ID: 4807074
    [No Abstract]   [Full Text] [Related]  

  • 2. [Electrocardiographic and rheographic modifications in arteriosclerotics treated with polysulfoester of pentosan (SP-54)].
    Aguglia V; Sgroi C; Cerasola GA
    Boll Soc Ital Cardiol; 1972; 17(2):65-75. PubMed ID: 5071185
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical evaluation of the therapeutic activity of the -pyridyl-carbinol ester of clofibric acid].
    Silingardi V; Renzi R; Mora A; Di Prisco AU
    Minerva Med; 1973 Mar; 64(16):751-69. PubMed ID: 4704721
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of clofibrate, Isopharm, on fat tolerance in atherosclerotic patients].
    Passowicz L
    Pol Tyg Lek; 1972 Jul; 27(30):1163-6. PubMed ID: 5073024
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic results with combination of pyridinolcarbamate and clofibrate in atherosclerotic patients].
    Valiensi M; Riboli E; Lombardi M
    Minerva Cardioangiol; 1976 Feb; 24(2):148-54. PubMed ID: 1256654
    [No Abstract]   [Full Text] [Related]  

  • 6. [Behavior of the curves of diffusion with albumin 131-I in subjects treated with clofibrate].
    Indovina I; Licata G; Custro N
    Boll Soc Ital Cardiol; 1973; 18(11):1057-63. PubMed ID: 4619972
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical and therapeutic evaluation of simfibrate compared toclofibrate in atherosclerotic patients].
    De Rosa G; Savi L; De Rosa E; Pola P; Boni P
    Clin Ter; 1979 Feb; 88(3):267-79. PubMed ID: 376218
    [No Abstract]   [Full Text] [Related]  

  • 8. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
    Pola P
    J Pharm Sci; 1975 Jan; 64(1):261-9. PubMed ID: 1094102
    [No Abstract]   [Full Text] [Related]  

  • 9. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
    Pola P
    Minerva Cardioangiol; 1975 Apr; 23(4):261-9. PubMed ID: 1095958
    [No Abstract]   [Full Text] [Related]  

  • 10. [Arteriosclerosis with special reference to anticholesteremic agents].
    Murakami M; Sekimoto H; Nakada I; Takegoshi T; Iwaki N
    Naika; 1970 Jun; 25(6):1082-6. PubMed ID: 5431239
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes of the electrophoretic tracing of the serum glycoproteins in arteriosclerotic patients treated with clofibrate].
    Notarbartolo A; Rini GB; Campisi D
    Boll Soc Ital Cardiol; 1973; 18(4):373-8. PubMed ID: 4807077
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of clofibrate on serum lipid pattern in patients with arteriosclerosis].
    Markiewicz K; Walasek L; Pelka W; Lutz W
    Pol Tyg Lek; 1973 Jul; 28(30):1144-7. PubMed ID: 4732710
    [No Abstract]   [Full Text] [Related]  

  • 13. [The clofibrate-dipyridamole combination in the prevention and therapy of arteriosclerotic vascular disease and its complications].
    Cucinotta D; Ferretti PG; Daccò L; Mazzera F
    G Clin Med; 1977; 58(11-12):475-86. PubMed ID: 608558
    [No Abstract]   [Full Text] [Related]  

  • 14. [Speed of propagation of the rheographic wave in the lower extremities in normal subjects, patients with arteriosclerosis obliterans and subjects with peripheral arterial sclerosis].
    Di Renzi L; Leggio F; Cassone R; Lucisano V; Gambelli G
    Riv Med Aeronaut Spaz; 1970; 33(3):307-29. PubMed ID: 5513754
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of clofibrate and pyridinol carbamate singly or in combination in the antiarteriosclerotic therapy].
    Meciani L; Boeri S; Ricci G
    Minerva Cardioangiol; 1974; 22(7-8):512-42. PubMed ID: 4606052
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of hepatic function before and after administration of therapeutic doses of clofibrate].
    Dal Monte PR; Menghi B; Cremonini R; Sarti F; Toscano S
    Minerva Med; 1971 Dec; 62(97):4815-29. PubMed ID: 5131188
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of clofibrate on fibrinolysis and platelet adhesiveness and aggregation in patients with arteriosclerosis].
    Cajozzo A; Abbadessa V; Carreca I; Perricone R
    Boll Soc Ital Cardiol; 1973; 18(4):361-7. PubMed ID: 4807075
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of long-term administration of clofibrate on the composition of blood lipids in patients with atherosclerosis.
    Poleszak J; Korolko A
    Pol Med J; 1972; 11(2):250-6. PubMed ID: 5071512
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of a beta-blocking agent on the peripheral arterial circulation under basal conditions and after postural changes of the limbs. Rheographic study. II. Arteriopathic subjects].
    Del Guercio R; Conti G; Savarese A; Piemontese M; Valva M
    Clin Ter; 1969 Jun; 49(5):461-71. PubMed ID: 4393994
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of hyperbarism and hyperbaric oxygenation on cerebral circulation. (Rheographic studies)].
    Di Pretoro L; Forti G; Adami V; Mastrostefano MP
    Acta Anaesthesiol; 1968; 19():Suppl 9:73-84. PubMed ID: 5757556
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.